Related Experiment Video
Updated: Feb 4, 2026
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Closure of mid-bore venotomies with VASCADE VCD after right and left heart catheterization
Hosam Hmoud1, Matteo Sturla2, Louis Delucia3
1St. George's University School of Medicine, West Indies, Grenada.
Insights
The VASCADE vascular closure device effectively achieved rapid hemostasis in 99% of patients undergoing venous closure after heart catheterization, with no major complications. This demonstrates its safety and efficiency for venous access site management.
Area of Science:
- Cardiovascular Interventions
- Vascular Access Management
Background:
- The VASCADE closure device is commonly used for arterial access sites.
- Limited data exist on its efficacy for venous access sites after procedures like right-heart catheterization.
Purpose of the Study:
- To evaluate the clinical outcomes of the VASCADE device for closing 7F femoral venotomies.
- To assess the safety and efficacy of VASCADE in venous closure post-catheterization.
Main Methods:
- Retrospective analysis of 102 consecutive patients undergoing venous closure with VASCADE.
- Data collected included patient demographics, comorbidities, and periprocedural therapies.
- Follow-up was conducted for 30 days post-procedure.
Main Results:
- Successful hemostasis was achieved in 99% (101/102) of patients within 3 minutes.
- One instance of device failure required manual compression; no other complications occurred.
- No adverse events were reported within the 30-day follow-up period.
Conclusions:
- The VASCADE device is highly effective for achieving venous hemostasis.
- Vascular closure devices can enhance patient experience, safety, and procedural efficiency.
Objective:
This single-center, retrospective analysis investigated the clinical outcomes of a novel vascular closure device (VASCADE, Cardiva Medical, Santa Clara, CA) for closure of 7F femoral venotomies.
Background:
The VASCADE closure device has been widely used to close arteriotomy sites following femoral procedures; however, little data have been published regarding the device's utility in closure of venotomy sites after procedures such as right-heart catheterization.
Methods:
This was a retrospective analysis of outcomes in 102 consecutive patients who underwent venous closure using the VASCADE device following diagnostic right and left-heart catheterization between April 2016 to May 2018. Patients' age, gender, valvular disease status, comorbidities, and periprocedural use of antiplatelet/anticoagulant therapy were analyzed.
Results:
Closure was successful in 99% (101/102) of patients with respect to achieving the primary outcome of rapid hemostasis in ≤3 min. There was one device failure requiring manual compression, with no further complications. There were no other related adverse events or complications through 30 days of follow-up.
Conclusions:
The VASCADE device achieved venous hemostasis in nearly all our patients. We believe devices for venous closure can aid in improving patient experience, safety, and efficiency during these procedures.
Related Concept Videos
01:24Cardiac Catheterization III: Left Heart Catheterization
01:21Cardiac Catheterization II: Right Heart Catheterization
01:27Anatomy of the Heart
01:20Anatomy of the Heart
The heart has three layers: the innermost endocardium, the muscular myocardium, and the outer epicardium, all working together for optimal cardiac function.
Chambers of the Heart
The heart is made up of four...
01:28Angle Closure Glaucoma: Treatment
01:28Cardiac Catheterization I: Pre-Procedure Overview